UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008523
Receipt number R000009999
Scientific Title Study of FDG-PET scanning conditions with Discovery-690 PET/CT on healthy volunteers and patients.
Date of disclosure of the study information 2012/07/24
Last modified on 2016/08/24 09:19:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of FDG-PET scanning conditions with Discovery-690 PET/CT on healthy volunteers and patients.

Acronym

New-PETCT

Scientific Title

Study of FDG-PET scanning conditions with Discovery-690 PET/CT on healthy volunteers and patients.

Scientific Title:Acronym

New-PETCT

Region

Japan


Condition

Condition

1)Normal healthy volunteer
2)Patients with or suspected of cancer who undergo diagnostic FDG-PET scan.

Classification by specialty

Radiology Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate image quality of FDG PET using the new PET/CT (Discovery-690) scanner with a variety of new features of data acquisition.

Basic objectives2

Others

Basic objectives -Others

For healthy volunteers, FDG is injected and PET scan is performed with Discovery-690 using various data acquisition protocols.
For patients, PET scan is performed with Discovery-690 just after they have finished routine diagnostic FDG PET/CT scan with Discovery-STEP.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

1)Evaluation of image quality based on the Society Guideline.
2)Comparison of PET images with those acquired in routine clinical scan.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

FDG-PET/CT scan with Discovery-690 scanner.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy voulunteer (n=12)
1)Informed concent is obtained.
2)Healthy voulunteer.
Patients (n=12)
1)Consent of the referring physician.
2)Informed concent is obtained.

Key exclusion criteria

Healthy voulunteer:
1)Cannot keep the supine position for 60 minutes.
2)Possibility of incomplete scan.
3)Unable to fast for six hours before the PET.
4)Substantial radiation exposure besides this study.
5)Possibility of pregnancy.
6)Subjects for diagnostic PET scan covered by insurance.
7)Regarded as unsuitable by investigators.
For patients:
1)Scheduled to undergo contrast enhanced CT after rotine PET/CT.
2)Scheduled to undergo delayed scan as rotine PET/CT
3)Cannot keep the supine position for 35 minutes.
4)Possibility of incomplete scan.
5)Regarded as unsuitable by investigator.

Target sample size

24


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michio Senda

Organization

Institute of Biomedical Research and Innovation

Division name

Division of Molecular Imaging

Zip code


Address

2-2,Minatojima-Minamimachi, Chuo-ku, Kobe

TEL

078-304-5212

Email



Public contact

Name of contact person

1st name
Middle name
Last name Kumiko Hirooka

Organization

Institute of Biomedical Research and Innovation

Division name

Division of Molecular Imaging

Zip code


Address

2-2,Minatojima-Minamimachi, Chuo-ku, Kobe

TEL

078-304-5212

Homepage URL


Email



Sponsor or person

Institute

Institute of Biomedical Research and Innovation

Institute

Department

Personal name



Funding Source

Organization

Foundation of Biomedical Research and Innovation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

先端医療センター(兵庫県)


Other administrative information

Date of disclosure of the study information

2012 Year 07 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 06 Month 08 Day

Date of IRB


Anticipated trial start date

2012 Year 07 Month 24 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 07 Month 24 Day

Last modified on

2016 Year 08 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009999